Division of Cardiology, Hartford Hospital, 80 Seymour Street, Hartford, CT, 06102, USA.
Department of Medicine, Mount Sinai Hospital, New York, NY, USA.
J Nucl Cardiol. 2017 Aug;24(4):1200-1213. doi: 10.1007/s12350-016-0427-1. Epub 2016 Mar 15.
Increasing numbers of patients are undergoing transcatheter aortic valve replacement, which often involves assessment of coronary artery disease ischemic burden. The safety and diagnostic accuracy of vasodilator stress agents in patients with severe aortic stenosis (AS) undergoing SPECT myocardial perfusion imaging (MPI) has not been established.
Patients with severe AS (valve area <1 cm) on echocardiography who underwent vasodilator stress SPECT MPI at two centers were identified. Patients with aortic valve intervention prior to MPI or who underwent concurrent exercise during stress testing were excluded. AS patients were matched to controls without AS based on age, gender, BMI, ejection fraction, and stress agent. Symptoms, serious adverse events, hemodynamic response, and correlation to invasive angiography were assessed.
A total of 95 cases were identified with 45% undergoing regadenoson, 31% dipyridamole, and 24% adenosine stress. A significant change in systolic blood pressure (BP), cases vs controls, was observed with adenosine [-17.9 ± 20.1 vs -2.6 ± 24.9 P = .03)], with a trend toward significance with regadenoson [-16.8 ± 20.3 vs -9.4 ± 17.9 (P = .08)] and dipyridamole [-17.8 ± 20.6 vs -9.0 ± 12.1 (P = .05)]. The change in heart rate was significantly different only for adenosine [5.3 ± 16.8 vs 14.2 ± 10.8 (P = .04)]. Overall, 45% of cases vs 24% of controls (P = .004) had a >20 mmHg decrease in systolic BP. Age, BMI, and resting systolic BP were related to a >20 mmHg decrease in systolic BP on univariate analysis, although only higher resting systolic BP was a predictor on multivariate analysis. In 33 patients who underwent angiography, the sensitivity, specificity, and diagnostic accuracy of vasodilator stress MPI was 77%, 69%, and 73%, respectively. No serious adverse events occurred in the severe AS patients.
Severe AS patients are more likely to have a hemodynamically significant decrease in systolic BP with vasodilator stress. There were no serious adverse events in this severe AS cohort with good diagnostic performance of MPI compared to angiography.
越来越多的患者接受经导管主动脉瓣置换术,该手术常需要评估冠状动脉疾病的缺血负担。在接受单光子发射计算机断层扫描心肌灌注显像(SPECT MPI)的严重主动脉瓣狭窄(AS)患者中,使用血管扩张剂应激剂的安全性和诊断准确性尚未确定。
在两个中心,对超声心动图显示严重 AS(瓣口面积<1cm)的患者进行血管扩张剂应激 SPECT MPI 检查。排除在 MPI 前接受主动脉瓣干预或在应激测试期间同时进行运动的患者。根据年龄、性别、BMI、射血分数和应激剂,将 AS 患者与无 AS 的对照组进行匹配。评估症状、严重不良事件、血流动力学反应以及与有创血管造影的相关性。
共确定 95 例患者,其中 45%接受雷卡诺生、31%接受双嘧达莫、24%接受腺苷应激。与对照组相比,接受腺苷治疗的患者收缩压(BP)变化显著[-17.9±20.1 比-2.6±24.9,P=0.03],雷卡诺生治疗组也有下降趋势[-16.8±20.3 比-9.4±17.9(P=0.08)],双嘧达莫治疗组也有下降趋势[-17.8±20.6 比-9.0±12.1(P=0.05)]。仅腺苷治疗组的心率变化有显著差异[5.3±16.8 比 14.2±10.8(P=0.04)]。总体而言,与对照组相比,有 45%的病例(P=0.004)收缩压下降>20mmHg。单变量分析显示,年龄、BMI 和静息收缩压与收缩压下降>20mmHg 相关,但只有较高的静息收缩压是多变量分析中的预测因素。在 33 例接受血管造影的患者中,血管扩张剂应激 MPI 的敏感性、特异性和诊断准确性分别为 77%、69%和 73%。严重 AS 患者无严重不良事件发生。
严重 AS 患者在接受血管扩张剂应激时更有可能出现收缩压有临床意义的下降。与血管造影相比,该严重 AS 队列中 MPI 的诊断性能良好,无严重不良事件发生。